BB BIOTECH AG 4
4 · Radius Health, Inc. · Filed Aug 30, 2022
Insider Transaction Report
Form 4
BIOTECH TARGET N V
10% Owner
Transactions
- Disposition from Tender
Common Stock
2022-08-11$10.00/sh−8,733,538$87,335,380→ 0 total
Footnotes (1)
- [F1]Pursuant to the Agreement and Plan of Merger (the "Merger Agreement") dated as of June 23, 2022, by and among the Issuer, Ginger Acquisition, Inc. ("Parent") and Ginger Merger Sub, Inc. ("Purchaser"), the Issuer merged with and into Purchaser on August 15, 2022, following a tender offer by Purchaser (the "Offer") to purchase each outstanding share of the Issuer's common stock in exchange for (i) $10.00, in cash, without interest and less applicable tax withholdings, plus (ii) one contractual contingent value right, which represents the right to receive a contingent payment of $1.00 (without interest thereon) upon the satisfaction of certain conditions (collectively, the "Offer Price"). Pursuant to the Merger Agreement and the Offer, the Purchaser acquired all of the shares of the Company held by the Reporting Persons and merged with and into the Issuer.